Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-055172
Filing Date
2018-10-16
Accepted
2018-10-16 17:58:45
Documents
2
Period of Report
2018-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2116
2 POA DOCUMENT poa.txt EX-24.3_813714 3452
  Complete submission text file 0001209191-18-055172.txt   7054
Mailing Address ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVE SAN DIEGO CA 92121
Business Address
HOFFMAN ROBERT (Reporting) CIK: 0001166288 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36361 | Film No.: 181125127

Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations